Glaukos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
1,094
Employees1,094
Headquarters
Aliso Viejo, California
HeadquartersAliso Viejo, California
Founded
1998
Founded1998
Employees
1,094
Employees1,094

GKOS Key Statistics

Market cap
7.34B
Market cap7.34B
Price-Earnings ratio
-38.15
Price-Earnings ratio-38.15
Dividend yield
Dividend yield
Average volume
640.36K
Average volume640.36K
High today
$126.99
High today$126.99
Low today
$122.53
Low today$122.53
Open price
$122.53
Open price$122.53
Volume
28.66K
Volume28.66K
52 Week high
$130.23
52 Week high$130.23
52 Week low
$73.16
52 Week low$73.16

Stock Snapshot

As of today, Glaukos(GKOS) shares are valued at $126.38. The company's market cap stands at 7.34B, with a P/E ratio of -38.15.

On 2026-04-20, Glaukos(GKOS) stock traded between a low of $122.53 and a high of $126.99. Shares are currently priced at $126.38, which is +3.1% above the low and -0.5% below the high.

Glaukos(GKOS) shares are trading with a volume of 28.66K, against a daily average of 640.36K.

During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $130.23 at its peak.

During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $130.23 at its peak.

GKOS News

Simply Wall St 2d
Assessing Glaukos Valuation After Recent Share Price Momentum

Advertisement Why Glaukos (GKOS) Is On Investors’ Radars Glaukos (GKOS) has drawn fresh attention after its recent share price gains, with the stock up about...

Assessing Glaukos Valuation After Recent Share Price Momentum
TipRanks 5d
Glaukos receives permanent J-code for Epioxa

Glaukos (GKOS) Corporation announced the U.S. Centers for Medicare and Medicaid Services has assigned a unique, permanent Healthcare Common Procedure Coding Sys...

Analyst ratings

93%

of 14 ratings
Buy
92.9%
Hold
7.1%
Sell
0%

People also own

Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.